意大利流行的葡萄球菌克隆中新的利奈唑胺耐药多种机制的令人担忧趋势。
Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy.
机构信息
University of Catania, Catania, Italy.
出版信息
J Clin Microbiol. 2013 Apr;51(4):1256-9. doi: 10.1128/JCM.00098-13. Epub 2013 Jan 23.
Abstract
In order to assess the frequency of clinically relevant linezolid-resistant staphylococcal isolates, and the role of linezolid in maintaining and coselecting multiple resistance mechanisms (cfr, 23S rRNA, L3/L4 mutations), a prospective Italian study was performed from 2010 to 2011 to confirm the diffusion of three major multidrug-resistant clones (ST2, ST5, ST23).
摘要
为了评估临床相关的利奈唑胺耐药葡萄球菌分离株的频率，以及利奈唑胺在维持和共同选择多种耐药机制（cfr、23S rRNA、L3/L4 突变）方面的作用，一项前瞻性意大利研究于 2010 年至 2011 年进行，以确认三种主要的多药耐药克隆（ST2、ST5、ST23）的扩散。
相似文献
1
Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy.意大利流行的葡萄球菌克隆中新的利奈唑胺耐药多种机制的令人担忧趋势。
J Clin Microbiol. 2013 Apr;51(4):1256-9. doi: 10.1128/JCM.00098-13. Epub 2013 Jan 23.
2
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy.利奈唑胺耐药葡萄球菌菌血症：意大利多中心病例对照研究。
Int J Antimicrob Agents. 2015 Mar;45(3):255-61. doi: 10.1016/j.ijantimicag.2014.12.008. Epub 2014 Dec 30.
3
Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.通过全基因组测序确定凝固酶阴性葡萄球菌对利奈唑胺耐药的机制。
mBio. 2014 May 13;5(3):e00894-14. doi: 10.1128/mBio.00894-14.
4
Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.中国多中心研究中耐利奈唑胺的肠球菌和科氏葡萄球菌临床分离株：分子流行病学和耐药机制。
Int J Antimicrob Agents. 2013 Oct;42(4):317-21. doi: 10.1016/j.ijantimicag.2013.06.008. Epub 2013 Jul 20.
5
Co-infection by two linezolid-resistant coagulase-negative staphylococci with two different resistance determinants.两种耐利奈唑胺凝固酶阴性葡萄球菌合并两种不同耐药决定簇的共同感染。
Scand J Infect Dis. 2012 Dec;44(12):978-81. doi: 10.3109/00365548.2012.704151. Epub 2012 Jul 25.
6
Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.美国医院表皮葡萄球菌临床分离株的分子流行病学研究。
Antimicrob Agents Chemother. 2012 Sep;56(9):4656-61. doi: 10.1128/AAC.00279-12. Epub 2012 Jun 11.
7
First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization.墨西哥首次报告由cfr引起的对利奈唑胺耐药的葡萄球菌临床分离株：体内cfr基因转移的证据
J Clin Microbiol. 2010 Aug;48(8):3041-3. doi: 10.1128/JCM.00880-10. Epub 2010 Jun 2.
8
Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.中国上海两家教学医院分离出的葡萄球菌和肠球菌中利奈唑胺耐药机制研究
BMC Microbiol. 2014 Nov 25;14:292. doi: 10.1186/s12866-014-0292-5.
9
Linezolid-Resistant Staphylococcus epidermidis, Portugal, 2012.耐利奈唑胺的表皮葡萄球菌，葡萄牙，2012年。
Emerg Infect Dis. 2014 May;20(5):903-5. doi: 10.3201/eid2005.130783.
10
Molecular characterization of linezolid-resistant CoNS isolates in Japan.日本耐利奈唑酮凝固酶阴性葡萄球菌分离株的分子特征。
J Antimicrob Chemother. 2015 Mar;70(3):658-63. doi: 10.1093/jac/dku443. Epub 2014 Nov 6.
引用本文的文献
1
Characterization of clinical isolates from hospitalized patients with bloodstream infection obtained in two time periods.两个时期住院血流感染患者临床分离株的特征。
PeerJ. 2022 Oct 4;10:e14030. doi: 10.7717/peerj.14030. eCollection 2022.
2
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.革兰阳性菌和革兰阴性菌中的移动恶唑烷酮类耐药基因。
Clin Microbiol Rev. 2021 Jun 16;34(3):e0018820. doi: 10.1128/CMR.00188-20. Epub 2021 Jun 2.
3
Synergy of Linezolid with Several Antimicrobial Agents against Linezolid-Methicillin-Resistant Staphylococcal Strains.利奈唑胺与多种抗菌药物对耐利奈唑胺和耐甲氧西林葡萄球菌菌株的协同作用。
Antibiotics (Basel). 2020 Aug 9;9(8):496. doi: 10.3390/antibiotics9080496.
4
Molecular epidemiology of coagulase-negative bloodstream isolates: detection of Staphylococcus epidermidis ST2, ST7 and linezolid-resistant ST23.凝固酶阴性血流分离株的分子流行病学：表皮葡萄球菌 ST2、ST7 和耐利奈唑烷 ST23 的检测。
Braz J Infect Dis. 2016 Sep-Oct;20(5):419-28. doi: 10.1016/j.bjid.2016.05.007. Epub 2016 Jul 6.
5
Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.细菌核糖体蛋白L3中的突变及其与抗生素耐药性的关联。
Antimicrob Agents Chemother. 2015;59(6):3518-28. doi: 10.1128/AAC.00179-15. Epub 2015 Apr 6.
6
Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.抗α毒素单克隆抗体与抗生素联合治疗可改善金黄色葡萄球菌皮肤坏死模型的疾病转归并加速愈合。
Antimicrob Agents Chemother. 2015 Jan;59(1):299-309. doi: 10.1128/AAC.03918-14. Epub 2014 Oct 27.
7
A cfr-positive clinical staphylococcal isolate from India with multiple mechanisms of linezolid-resistance.一株来自印度的临床分离葡萄球菌，携带对利奈唑胺耐药的多种机制，且cfr基因呈阳性。
Indian J Med Res. 2014 Mar;139(3):463-7.
本文引用的文献
1
Linezolid Resistance in Staphylococci.葡萄球菌对利奈唑胺的耐药性
Pharmaceuticals (Basel). 2010 Jun 24;3(7):1988-2006. doi: 10.3390/ph3071988.
2
Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.美国医院表皮葡萄球菌临床分离株的分子流行病学研究。
Antimicrob Agents Chemother. 2012 Sep;56(9):4656-61. doi: 10.1128/AAC.00279-12. Epub 2012 Jun 11.
3
A multidrug-resistant Staphylococcus epidermidis clone (ST2) is an ongoing cause of hospital-acquired infection in a Western Australian hospital.一株耐多药表皮葡萄球菌（ST2）克隆株是西澳一家医院院内感染的持续传染源。
J Clin Microbiol. 2012 Jun;50(6):2147-51. doi: 10.1128/JCM.06456-11. Epub 2012 Mar 21.
4
Resistance to linezolid caused by modifications at its binding site on the ribosome.核糖体结合部位修饰导致对利奈唑胺的耐药性。
Antimicrob Agents Chemother. 2012 Feb;56(2):603-12. doi: 10.1128/AAC.05702-11. Epub 2011 Dec 5.
5
Characteristics related to antimicrobial resistance and biofilm formation of widespread methicillin-resistant Staphylococcus epidermidis ST2 and ST23 lineages in Rio de Janeiro hospitals, Brazil.巴西里约热内卢医院中广泛流行的耐甲氧西林表皮葡萄球菌 ST2 和 ST23 谱系的与抗菌药物耐药性和生物膜形成相关的特征。
Diagn Microbiol Infect Dis. 2012 Jan;72(1):32-40. doi: 10.1016/j.diagmicrobio.2011.09.017. Epub 2011 Nov 17.
6
Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients.耐甲氧西林和利奈唑胺的表皮葡萄球菌医院感染爆发与重症监护病房患者的导管相关感染有关。
Int J Med Microbiol. 2011 Apr;301(4):354-8. doi: 10.1016/j.ijmm.2010.11.001. Epub 2011 Jan 14.
7
DNA methylase modifications and other linezolid resistance mutations in coagulase-negative staphylococci in Italy.意大利凝固酶阴性葡萄球菌中的 DNA 甲基酶修饰和其他利奈唑胺耐药突变。
J Antimicrob Chemother. 2010 Nov;65(11):2336-40. doi: 10.1093/jac/dkq344. Epub 2010 Sep 18.
8
Resistance to linezolid in a porcine Clostridium perfringens strain carrying a mutation in the rplD gene encoding the ribosomal protein L4.携带 rplD 基因突变的猪梭状芽孢杆菌对利奈唑胺的耐药性。rplD 基因编码核糖体蛋白 L4。
Antimicrob Agents Chemother. 2010 Mar;54(3):1351-3. doi: 10.1128/AAC.01208-09. Epub 2010 Jan 11.
9
Polyphyletic emergence of linezolid-resistant staphylococci in the United States.美国利奈唑胺耐药葡萄球菌的多系起源。
Antimicrob Agents Chemother. 2010 Feb;54(2):742-8. doi: 10.1128/AAC.00621-09. Epub 2009 Nov 23.
10
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.核糖体蛋白 L3 中的突变与临床来源的葡萄球菌对唑烷酮类药物的耐药性有关。
Antimicrob Agents Chemother. 2009 Dec;53(12):5275-8. doi: 10.1128/AAC.01032-09. Epub 2009 Oct 5.
Zotero 插件